logo

For the Inventor, By the Inventor

LATE OF Mannheim-Waldhof, Germany

Kurt Stach, Deceased

USPTO Granted Patents = 16

Average Co-Inventor Count = 5.6

ph-index = 7

Forward Citations = 202(Granted Patents)


Location History:

  • LATE OF Mannheim, DE (1978)
  • LATE OF Mannheim-Waldhof, DE (US) (1979)
  • LATE OF Mannheim-Waldhof, DE (1976 - 1981)

Company Filing History:

goldMedal15 out of 1,164 
 
Boehringer Mannheim Gmbh
 patents
silverMedal1 out of 1 
 
C.f. Boehringer & Soehne Gmbh
 patent

Years Active: 1976-1981

Loading Chart...
16 patents (USPTO):Explore Patents
1. 4243807 - 4-Phenoxymethyl-piperidines (1981-01-06),
2. 4238506 - Hypoglycaemically and hypolipidaemically active derivatives of (1980-12-09),
3. 4229464 - Aminopropanol substituted indole compounds and compositions for the (1980-10-21),
4. 4172136 - 3-Nitropyrazole compounds and anti-microbial compositions (1979-10-23),
5. 4151303 - Phenoxyalkylcarboxylic acid compounds and serum-lipid and triglyceride (1979-04-24),
6. 4113871 - Hypoglycemically and hypolipidemically active derivatives of (1978-09-12),
7. 4107299 - Cardioactive 12-epi-digoxin and derivatives thereof (1978-08-15),
8. 4105772 - 3-Nitropyrazole compounds and anti-microbial compositions (1978-08-08),
9. 4092416 - Benzopyrone derivatives exhibiting anti-allergic activity (1978-05-30),
10. 4087520 - Lowering blood pressure with new (1978-05-02),
11. 4086347 - 9-[3-(4-Phenoxymethylpiperidino)-propyl]-adenines (1978-04-25),
12. 4070373 - Tricyclic aminoalkyl derivatives (1978-01-24),
13. 4034096 - Nitrogen containing derivatives of cyclopenteno-quinolone compounds and (1977-07-05),
14. 4033967 - Cyclopenteno[1,2-h]quinol-4-one derivatives (1977-07-05),
15. 4016262 - Therapeutic compositions and methods employing N(6)-disubstituted (1977-04-05),

Title: **The Legacy of Inventor Kurt Stach**

Introduction

Kurt Stach was a notable inventor known for his significant contributions in the field of medicinal chemistry. Based in Mannheim-Waldhof, Germany, he left a legacy of 16 patents that highlight his innovative spirit and dedication to the advancement of healthcare solutions.

Latest Patents

One of Stach's latest patents includes the development of 4-Phenoxymethyl-piperidines, which are particularly useful as intermediates in creating anti-hypertensive agents. This invention describes a formula where R can be hydrogen, halogen, nitro, lower alkyl, or lower alkoxy. The production method involves a condensation process with propyl chloride followed by a reaction with adenine or a propyl indole. Additionally, he worked on hypoglycaemically and hypolipidaemically active derivatives of Phenyl-alkane-carboxylic acids, showcasing a diverse range of medicinal applications that reflect his expertise in chemical compounds.

Career Highlights

Throughout his career, Kurt Stach played a pivotal role in significant pharmaceutical companies, including Boehringer Mannheim GmbH and C.F. Boehringer & Soehne GmbH. His work at these companies allowed him to apply his knowledge and skills in practical and impactful ways, resulting in innovations that have benefited the medical field.

Collaborations

Stach was known for his collaborative efforts with other prominent scientists, including Max Thiel and Wolfgang Schaumann. These partnerships fostered a creative environment that led to groundbreaking advancements and made a lasting impact on their respective fields.

Conclusion

Kurt Stach's contributions to science and medicine through his patents and collaborations highlight the importance of innovation in healthcare. His work continues to inspire future generations of inventors and scientists to pursue their own paths in the world of inventions and patents. The legacy he left behind is a testament to the power of creativity and collaboration in advancing human health and well-being.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…